Back to top anchor

Self-sampling for HPV screening: a community trial

Year:
2016
Duration:
56 months
Approved budget:
$1,199,764.36
Researchers:
Professor John Potter
Health issue:
Cancer (oncology)
Proposal type:
Project
Lay summary
There are major ethnic inequalities in cervical cancer screening, incidence, and mortality in New Zealand. Human papillomavirus (HPV) is the main cause of cervical cancer. Screening for high-risk HPV genotypes (with appropriate subsequent treatment) could prevent nearly all cervical cancers. We hypothesize that offering the opportunity for self-sampling to obtain a cervical specimen for HPV testing will increase participation rates in the National Cervical Screening Programme and will thus decrease incidence of, and mortality from, cervical cancer. We will conduct a community trial in Maori, Pacific and Asian women, comparing invitation for cytology with invitation for self-sampling. We will determine whether un- and under-screened women find self-sampling acceptable and establish which factors affect their perceptions. The study aims to contribute to decreasing inequalities in New Zealand by exploring the use of a new cervical screening method that women who do not currently undergo screening may find acceptable.